SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001293971-24-000017
Filing Date
2024-05-03
Accepted
2024-05-03 07:00:19
Documents
15
Period of Report
2024-04-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K blue-20240430.htm   iXBRL 8-K 38177
2 EX-10.1 ex-101lsa.htm EX-10.1 813532
3 EX-10.2 ex-102lsaamend1.htm EX-10.2 54820
  Complete submission text file 0001293971-24-000017.txt   1182282

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT blue-20240430.xsd EX-101.SCH 1913
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT blue-20240430_lab.xml EX-101.LAB 21880
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT blue-20240430_pre.xml EX-101.PRE 12516
18 EXTRACTED XBRL INSTANCE DOCUMENT blue-20240430_htm.xml XML 2718
Mailing Address 455 GRAND UNION BOULEVARD SOMERVILLE MA 02145
Business Address 455 GRAND UNION BOULEVARD SOMERVILLE MA 02145 339-499-9300
bluebird bio, Inc. (Filer) CIK: 0001293971 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35966 | Film No.: 24910753
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)